Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Longman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Cardiovascular Pharmacology|January 1, 1988
Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandilS D Longman, J C Clapham, C Wilson, et al.
Current Biology : CB|December 19, 2001
Multiple interactions between SRm160 and SR family proteins in enhancer-dependent splicing and development of C. elegansD Longman, T McGarvey, S McCracken, et al.
Journal of Cardiovascular Pharmacology|July 1, 1986
BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal modelsR E Buckingham, J C Clapham, T C Hamilton, et al.
Arzneimittel-Forschung|April 1, 1988
Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogueT C Hamilton, D R Howlett, S D Longman, et al.
Arzneimittel-Forschung|April 1, 1991
Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal modelsJ C Clapham, T C Hamilton, S D Longman, et al.
Bone|November 7, 2016
Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfectaM Balasubramanian, J Hurst, S Brown, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cardiovascular Pharmacology|January 1, 1988
Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandilS D Longman, J C Clapham, C Wilson, et al.
Current Biology : CB|December 19, 2001
Multiple interactions between SRm160 and SR family proteins in enhancer-dependent splicing and development of C. elegansD Longman, T McGarvey, S McCracken, et al.
Journal of Cardiovascular Pharmacology|July 1, 1986
BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal modelsR E Buckingham, J C Clapham, T C Hamilton, et al.
Arzneimittel-Forschung|April 1, 1988
Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogueT C Hamilton, D R Howlett, S D Longman, et al.
Arzneimittel-Forschung|April 1, 1991
Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal modelsJ C Clapham, T C Hamilton, S D Longman, et al.
Bone|November 7, 2016
Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfectaM Balasubramanian, J Hurst, S Brown, et al.
Pageof 2